Cardiac Surgery With Cardiopulmonary Bypass
9
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Inhaled Nitric Oxide for Prevention of Postoperative AKI in High-Risk Cardiac Surgery Patients
Evaluation of Plasma Renin Concentrations in Cardiac Surgery
Perioperatively Assessed Biomarker I-FABP Level for Prediction of Acute Mesenteric Ischemia and Its Correlation With Acute Kidney Injury, Followed by Extracorporeal Circulation (aMIKI)
Transfusion in Cardiac Valve Surgery
Beta Blocker Use in Cardiac Surgery and Association With Postoperative Course
Left Atrial Appendage Occlusion Study III
Systematic Evaluation of Protamine Doze in Cardiac Surgery
Serum Phosphatemia Predictive Marker for AKI Diagnosis After Cardiac Surgery
A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery